AtheroGenics Cash Flow Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Net Operating Cash Flow | (37.4) | (56.4) | (27.0) |
| Net Investing Cash Flow | 18.0 | 43.3 | 30.4 |
| Net Financing Cash Flow | (5.5) | 0.0 | 1.7 |
| Net Change in Cash | (24.8) | (13.1) | 5.0 |
| Depreciation & Amortization | 4.5 | 2.6 | 1.0 |
| Capital Expenditures | (0.0) | (2.6) | (5.5) |
| Cash Dividends Paid | -- | -- | -- |
© 2009 Morningstar, Inc. Financial Data provided by
